This comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years.
The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
Current and Emerging Products
Contains 402 pages and 35 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including:
June 2015 | $3500 | View Details >>
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:
December 2013 | $2500 | View Details >>
This new 148-page report from Venture Planning Group reviews current instrumentation technologies, and profiles features of leading automated and semi-automated Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic analyzers. The report also presents strategic assessments of current and emerging suppliers of microbiology products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
February 2014 | $0 | View Details >>
This new report from Venture Planning Group provides strategic assessments of major suppliers of hemostasis diagnostic products, as well as emerging market entrants. The report presents analyses of major current and emerging suppliers of hemostasis instruments ans reagents, including:
January 2014 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research